Amid plans to transfer manufacturing for an investigational vaccine to a souped-up plant in Pennsylvania, GSK is parting ways ...

A global biopharmaceutical company headquartered in London announced the layoffs of 150 Massachusetts employees last week.

The Cambridge site of an international biotechnology company will cease manufacturing, leaving 150 people without a job.

British biopharmaceutical company GlaxoSmithKline will lay off 150 employees in its Cambridge operations by the end of March 2026, the company said in a notice to the state. The company said Monday ...

With GSK kicking its research and development engine into high gear in recent years, a shuffling of the scientific priorities is only natural. | With GSK kicking its R&D engine into high gear in ...

In an industry pining for investment activity, real estate investment trust Boston Properties (BXP) has agreed to sell a 45 percent interest in two life sciences developments valued at about $1.66 ...

Cambridge obtained the Binney Street Park land during a 2019 rezoning exchange with Google, according to Farooq. In order to maintain the number of public green spaces in the area, ...

The Dana-Farber Cancer Institute is getting into the life science funding biz with the launch of its venture arm Binney Street Capital. Dana-Farber is certainly no stranger to backing biotechs and ...

After exiting its California headquarters, Kronos Bio was based out of 301 Binney Street in Cambridge. Now that space is also going back on the market. Wednesday, July 23, 2025.

The square footage for the tower could come from the 250 Binney St. project highlighted in red. BXP. By Greg Ryan – Senior Reporter, Boston Business Journal. Oct 10, 2024.

BOSTON, Dec. 16, 2021 /PRNewswire/ -- Newmark announces the $1.2 billion recapitalization of 50 + 60 Binney Street, two state-of-the-art life scie ...

Moderna opened its new global headquarters at 325 Binney St. in Cambridge. Gary Higgins / Boston Business Journal Preview this article 1 min Moderna Inc.’s plan to put its R&D operations under ...